215 related articles for article (PubMed ID: 27875973)
1. Structural Modifications of Diarylpyrimidine-quinolone Hybrids as Potent HIV-1 NNRTIs with an Improved Drug Resistance Profile.
Mao TQ; He QQ; Chen WX; Tang GF; Chen FE; De Clercq E; Daelemans D; Pannecouque C
Curr Pharm Des; 2016; 22(46):6982-6987. PubMed ID: 27875973
[TBL] [Abstract][Full Text] [Related]
2. Anti-HIV diarylpyrimidine-quinolone hybrids and their mode of action.
Mao TQ; He QQ; Wan ZY; Chen WX; Chen FE; Tang GF; De Clercq E; Daelemans D; Pannecouque C
Bioorg Med Chem; 2015 Jul; 23(13):3860-8. PubMed ID: 25907370
[TBL] [Abstract][Full Text] [Related]
3. Targeting the hydrophobic channel of NNIBP: discovery of novel 1,2,3-triazole-derived diarylpyrimidines as novel HIV-1 NNRTIs with high potency against wild-type and K103N mutant virus.
Zhou Z; Liu T; Wu G; Kang D; Fu Z; Wang Z; De Clercq E; Pannecouque C; Zhan P; Liu X
Org Biomol Chem; 2019 Mar; 17(12):3202-3217. PubMed ID: 30839042
[TBL] [Abstract][Full Text] [Related]
4. Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors.
Yang S; Pannecouque C; Daelemans D; Ma XD; Liu Y; Chen FE; De Clercq E
Eur J Med Chem; 2013 Jul; 65():134-43. PubMed ID: 23707918
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of a new series of modified CH-diarylpyrimidines as drug-resistant HIV non-nucleoside reverse transcriptase inhibitors.
Meng G; Liu Y; Zheng A; Chen F; Chen W; De Clercq E; Pannecouque C; Balzarini J
Eur J Med Chem; 2014 Jul; 82():600-11. PubMed ID: 24952305
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel diarylpyrimidines as potent HIV-1 NNRTIs by investigating the chemical space of a less explored "hydrophobic channel".
Zhou Z; Liu T; Kang D; Huo Z; Wu G; Daelemans D; De Clercq E; Pannecouque C; Zhan P; Liu X
Org Biomol Chem; 2018 Feb; 16(6):1014-1028. PubMed ID: 29349445
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of DAPY-DPEs hybrids as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Wu HQ; Yao J; He QQ; Chen WX; Chen FE; Pannecouque C; De Clercq E; Daelemans D
Bioorg Med Chem; 2015 Feb; 23(3):624-31. PubMed ID: 25537532
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, and Evaluation of Thiophene[3,2-d]pyrimidine Derivatives as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Drug Resistance Profiles.
Kang D; Fang Z; Li Z; Huang B; Zhang H; Lu X; Xu H; Zhou Z; Ding X; Daelemans D; De Clercq E; Pannecouque C; Zhan P; Liu X
J Med Chem; 2016 Sep; 59(17):7991-8007. PubMed ID: 27541578
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and anti-HIV evaluation of novel 5-substituted diarylpyrimidine derivatives as potent HIV-1 NNRTIs.
Gao P; Song S; Wang Z; Sun L; Zhang J; Pannecouque C; De Clercq E; Zhan P; Liu X
Bioorg Med Chem; 2021 Jun; 40():116195. PubMed ID: 33979774
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and evaluation of novel HIV-1 NNRTIs with dual structural conformations targeting the entrance channel of the NNRTI binding pocket.
Meng Q; Chen X; Kang D; Huang B; Li W; Zhan P; Daelemans D; De Clercq E; Pannecouque C; Liu X
Eur J Med Chem; 2016 Jun; 115():53-62. PubMed ID: 26994843
[TBL] [Abstract][Full Text] [Related]
11. Bioisosterism-based design and enantiomeric profiling of chiral hydroxyl-substituted biphenyl-diarylpyrimidine nonnucleoside HIV-1 reverse transcriptase inhibitors.
Chen X; Ding L; Tao Y; Pannecouque C; De Clercq E; Zhuang C; Chen FE
Eur J Med Chem; 2020 Sep; 202():112549. PubMed ID: 32712537
[TBL] [Abstract][Full Text] [Related]
12. Novel piperidinylamino-diarylpyrimidine derivatives with dual structural conformations as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
Chen X; Liu X; Meng Q; Wang D; Liu H; De Clercq E; Pannecouque C; Balzarini J; Liu X
Bioorg Med Chem Lett; 2013 Dec; 23(24):6593-7. PubMed ID: 24239481
[TBL] [Abstract][Full Text] [Related]
13. Indazolyl-substituted piperidin-4-yl-aminopyrimidines as HIV-1 NNRTIs: Design, synthesis and biological activities.
Xiao T; Tang JF; Meng G; Pannecouque C; Zhu YY; Liu GY; Xu ZQ; Wu FS; Gu SX; Chen FE
Eur J Med Chem; 2020 Jan; 186():111864. PubMed ID: 31767136
[TBL] [Abstract][Full Text] [Related]
14. Discovery of biphenyl-substituted diarylpyrimidines as non-nucleoside reverse transcriptase inhibitors with high potency against wild-type and mutant HIV-1.
Jin K; Yin H; De Clercq E; Pannecouque C; Meng G; Chen F
Eur J Med Chem; 2018 Feb; 145():726-734. PubMed ID: 29353724
[TBL] [Abstract][Full Text] [Related]
15. Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 3: optimization of [1,2,4]triazolo[1,5-a]pyrimidine core via structure-based and physicochemical property-driven approaches.
Huang B; Li C; Chen W; Liu T; Yu M; Fu L; Sun Y; Liu H; De Clercq E; Pannecouque C; Balzarini J; Zhan P; Liu X
Eur J Med Chem; 2015 Mar; 92():754-65. PubMed ID: 25626145
[TBL] [Abstract][Full Text] [Related]
16. Design of the naphthyl-diarylpyrimidines as potent non-nucleoside reverse transcriptase inhibitors (NNRTIs) via structure-based extension into the entrance channel.
Jin X; Piao HR; Pannecouque C; De Clercq E; Zhuang C; Chen FE
Eur J Med Chem; 2021 Dec; 226():113868. PubMed ID: 34583311
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel diarylpyrimidines as potent HIV NNRTIs via a structure-guided core-refining approach.
Li X; Chen W; Tian Y; Liu H; Zhan P; De Clercq E; Pannecouque C; Balzarini J; Liu X
Eur J Med Chem; 2014 Jun; 80():112-21. PubMed ID: 24769349
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel potent HIV-1 inhibitors by exploiting the tolerant regions of the NNRTIs binding pocket.
Sun Y; Kang D; Da F; Zhang T; Li P; Zhang B; De Clercq E; Pannecouque C; Zhan P; Liu X
Eur J Med Chem; 2021 Mar; 214():113204. PubMed ID: 33567378
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of CHX-DAPYs as HIV-1 non-nucleoside reverse transcriptase inhibitors.
Yan ZH; Wu HQ; Chen WX; Wu Y; Piao HR; He QQ; Chen FE; De Clercq E; Pannecouque C
Bioorg Med Chem; 2014 Jun; 22(12):3220-6. PubMed ID: 24794751
[TBL] [Abstract][Full Text] [Related]
20. Exploiting the hydrophobic channel of the NNIBP: Discovery of novel diarylpyrimidines as HIV-1 NNRTIs against wild-type and K103N mutant viruses.
Fu Z; Zhang T; Zhou Z; Kang D; Sun L; Gao S; Cherukupalli S; De Clercq E; Pannecouque C; Liu X; Zhan P
Bioorg Med Chem; 2021 Jul; 42():116239. PubMed ID: 34090079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
